Provexis PLC PXS
LSE · United Kingdom · Health Technology
GBp 0.9400+0.01 (+1.62%)
Market closed· · GBp · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · GBp · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
The UK stock market has been experiencing some turbulence, with the FTSE 100 index recently closing lower due to weak trade data from China, highlighting concerns over global economic recovery. Despite these challenges, certain investment opportunities continue to attract attention, particularly those involving smaller or newer companies. Penny stocks—though a somewhat outdated term—still represent a niche area where investors can find potential growth opportunities when these companies are...
We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made...
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.